scispace - formally typeset
P

Paul M. O'Neill

Researcher at University of Liverpool

Publications -  298
Citations -  13684

Paul M. O'Neill is an academic researcher from University of Liverpool. The author has contributed to research in topics: Plasmodium falciparum & Artemisinin. The author has an hindex of 58, co-authored 287 publications receiving 12131 citations. Previous affiliations of Paul M. O'Neill include Dublin City University & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Artemisinins target the SERCA of Plasmodium falciparum

TL;DR: It is shown that artemisinins, but not quinine or chloroquine, inhibit the SERCA orthologue (PfATP6) of Plasmodium falciparum in Xenopus oocytes with similar potency to thapsigargin (another sesquiterpene lactone and highly specific SERCA inhibitor).
Journal ArticleDOI

Metabolism of fluorine-containing drugs.

TL;DR: The strategic value of fluorine substitution in drug design is discussed in terms of chemical structure and basic concepts in drug metabolism and drug toxicity.
Journal ArticleDOI

The molecular mechanism of action of artemisinin - the debate continues.

TL;DR: Recent evidence explaining bioactivation and potential molecular targets in the chemotherapy of malaria and cancer is discussed and artemisinins have also shown potent and broad anticancer properties in cell lines and animal models and are becoming established as anti-schistosomal agents.
Journal ArticleDOI

A medicinal chemistry perspective on artemisinin and related endoperoxides.

TL;DR: The explicit mechanism depicted in Scheme 1 is supported by the work of Berman and Adams and others, and it was proposed that the damage caused to the parasite’s FV membrane leads to vacuolar rupture and parasite autodigestion.
Journal ArticleDOI

4-Aminoquinolines—Past, present, and future; A chemical perspective

TL;DR: This review describes structure-activity relationships for the 4-aminoquinolines, along with views on the mechanism of action and parasite resistance, and potential approaches to the design of new synthetic derivatives.